日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders

神经退行性疾病中重叠的神经免疫机制和治疗靶点

De Marchi, Fabiola; Munitic, Ivana; Vidatic, Lea; Papić, Eliša; Rački, Valentino; Nimac, Jerneja; Jurak, Igor; Novotni, Gabriela; Rogelj, Boris; Vuletic, Vladimira; Liscic, Rajka M; Cannon, Jason R; Buratti, Emanuele; Mazzini, Letizia; Hecimovic, Silva

From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline

从基础研究到临床应用:ALS和FTD的创新疗法正在研发中。

Liscic, Rajka Maria; Alberici, Antonella; Cairns, Nigel John; Romano, Maurizio; Buratti, Emanuele

ALS and FTLD: two faces of TDP-43 proteinopathy

肌萎缩侧索硬化症和额颞叶痴呆:TDP-43蛋白病的两面性

Liscic, R M; Grinberg, L T; Zidar, J; Gitcho, M A; Cairns, N J

HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin.

HDDD2 是一种家族性额颞叶变性,其特征是泛素阳性、tau 蛋白阴性的包涵体,由前粒蛋白信号肽中的错义突变引起

Mukherjee Odity, Pastor Pau, Cairns Nigel J, Chakraverty Sumi, Kauwe John S K, Shears Shantia, Behrens Maria I, Budde John, Hinrichs Anthony L, Norton Joanne, Levitch Denise, Taylor-Reinwald Lisa, Gitcho Michael, Tu P-H, Tenenholz Grinberg Lea, Liscic Rajka M, Armendariz Javier, Morris John C, Goate Alison M